Last reviewed · How we verify

NCT03075176

Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy

Terminated NA Results posted Last updated 17 July 2023
What this trial tests

NA trial testing Wavefront optimized LASIK in Surgery in 39 participants. Terminated before completion.

Timeline
13 February 2017
Primary endpoint
12 August 2019
12 August 2019

Quick facts

Lead sponsorUniversity of Utah
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment39
Start date13 February 2017
Primary completion12 August 2019
Estimated completion12 August 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Utah

Who can join

21 and older, any sex, with Surgery or Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the difference in results between eyes that have been treated wavefront optimized laser vision correction (either LASIK or Photorefractive Keratectomy) compared to eyes treated with topography-guided laser vision correction (either LASIK or Photorefractive Keratectomy). Each participant will receive wavefront optimized correction in one eye and topography-guided correction in the other.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Wavefront excimer laser refractive surgery for adults with refractive errors.
    Li SM, Kang MT, Wang NL, Abariga SA. · · 2020 · cited 15× · PMID 33336797 · DOI 10.1002/14651858.cd012687.pub2

Verify or expand the search:

Other trials of Wavefront optimized LASIK

Trials testing the same drug.

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other University of Utah trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03075176.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing